The pharmacokinetic and safety profile of GS-5718 support the further development in inflammatory diseases with once-daily administrations.Kacey Anderson Shareholder of: Gilead Sciences, Employee of: Gilead Sciences, Chia-Hsiang Hsueh Shareholder of: Gilead Sciences, Employee of: Gilead Sciences, Oksana ...